[{"type": "title", "data": "ORTHO Fractured Hip Venous Thromboembolism (VTE) Prophylaxis (Module)"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "For patients awaiting emergency surgery, administer once/twice daily LMWH dosing as planned if surgery is cancelled and pushed to the following day, no later than 1900h"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Monitor patients with epidural catheter receiving anticoagulant prophylaxis for symptoms and signs of spinal hematoma"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "VTE RISK IS LOW", "value": ""}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "Early ambulation; no anticoagulant or no mechanical prophylaxis required"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH", "value": ""}, {"type": "note", "data": "Order pharmacologic prophylaxis except when:  - Active bleeding of clinical significance requiring intervention   - High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, epidural, pericardial, intraocular, retroperitoneal, intra-articular)   - Known major bleeding disorder or acquired coagulopathy (consider Hematology consult)   - Platelet count less than 50 x 10^9/L (consider Hematology consult)   - If history of Heparin-Induced Thrombocytopenia (HIT), DO NOT give LMWH or heparin. Consider fondaparinux (listed below) or consult Hematology / Internal Medicine for use of an alternative agent if eGFR less than 30 mL/min  - Patient already receiving therapeutic anticoagulation", "value": ""}, {"type": "order", "data": "VTE Prophylaxis Contraindication", "value": ""}, {"type": "sentence", "data": "Contraindication: Active Bleeding Requiring Intervention"}, {"type": "sentence", "data": "Contraindication: Risk of Serious Bleed in Critical Site"}, {"type": "sentence", "data": "Contraindication: Known Major Bleed Disorder/Coagulopathy"}, {"type": "sentence", "data": "Contraindication: Platelet Count Less Than 50 x 10^9/L"}, {"type": "sentence", "data": "Contraindication: Hx of Heparin-Induced Thrombocytopenia, DO NOT give LMWH or heparin"}, {"type": "sentence", "data": "Contraindication: Receiving Therapeutic Anticoagulant"}, {"type": "note", "data": "Reassess daily to start anticoagulant prophylaxis when contraindication resolves", "value": ""}, {"type": "note", "data": "Refer to VTE Risk Assessment and Thromboprophylaxis Recommendation", "value": ""}, {"type": "note", "data": "Pharmacologic prophylaxis for patients not requiring epidural / perineural analgesia", "value": ""}, {"type": "order", "data": "Hold Medication(s)", "value": ""}, {"type": "sentence", "data": "Clinical event: Planned Surgery, Medication(s) to be held: enoxaparin, Instructions: Do not administer enoxaparin if surgery is planned within the next 12 hours"}, {"type": "note", "data": "For patients receiving prophylactic subcutaneous enoxaparin up to 40 mg qdaily or dalteparin up to 5000 units qdaily or heparin up to 5000 units q8h:  - Do not remove epidural / perineural catheter for at least 12 hours after the last dose of LMWH (enoxaparin or dalteparin) or at least 4 hours after the last dose of heparin  - After catheter removal, do not administer LMWH (enoxaparin or dalteparin) for at least 4 hours or heparin for at least 1 hour", "value": ""}, {"type": "note", "data": "Epidural contraindicated if enoxaparin dose exceeds 40 mg daily or dalteparin dose exceeds 5000 units daily. Prescriber to order alternate anticoagulant if needed", "value": ""}, {"type": "note", "data": "Enoxaparin for eGFR 30 mL/min or greater", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, subcutaneous, q24h, drug form: syringe-inj, start: T;1800 [Less Than 41 kg]"}, {"type": "sentence", "data": "30 mg, subcutaneous, qAM, drug form: syringe-inj, start: T+1;1000 [Less Than 41 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, q24h, drug form: syringe-inj, start: T;1800 [41 - 101 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, q12h interval, drug form: syringe-inj, start: T;1800 [101 - 141 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, qAM, drug form: syringe-inj, start: T+1;1000 [41 - 101 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, q12h, drug form: syringe-inj, start: T+1;1000 [101 - 141 kg]"}, {"type": "sentence", "data": "60 mg, subcutaneous, q12h interval, drug form: syringe-inj, start: T;1800 [Greater Than or Equal To 141 kg]"}, {"type": "sentence", "data": "60 mg, subcutaneous, q12h, drug form: syringe-inj, start: T+1;1000 [Greater Than or Equal To 141 kg]"}, {"type": "note", "data": "Enoxaparin for eGFR 10 to 29 mL/min", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, subcutaneous, q24h, drug form: syringe-inj, start: T;1800 [Less Than 101 kg]"}, {"type": "sentence", "data": "30 mg, subcutaneous, qAM, drug form: syringe-inj, start: T+1;1000 [Less Than 101 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, q24h, drug form: syringe-inj, start: T;1800 [101 - 141 kg]"}, {"type": "sentence", "data": "40 mg, subcutaneous, qAM, drug form: syringe-inj, start: T+1;1000 [101 - 141 kg]"}, {"type": "sentence", "data": "60 mg, subcutaneous, q24h, drug form: syringe-inj, start: T;1800 [Greater Than or Equal To 141 kg]"}, {"type": "sentence", "data": "60 mg, subcutaneous, qAM, drug form: syringe-inj, start: T+1;1000 [Greater Than or Equal To 141 kg]"}, {"type": "note", "data": "Heparin for eGFR less than 10 mL/min or on dialysis", "value": ""}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "2,500 unit, subcutaneous, q12h interval, drug form: inj, start: T;1800 [Less Than 41 kg]"}, {"type": "sentence", "data": "2,500 unit, subcutaneous, q12h, drug form: inj, start: T+1;1000 [Less Than 41 kg]"}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q12h interval, drug form: inj, start: T;1800 [41 - 101 kg]"}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q12h, drug form: inj, start: T+1;1000 [41 - 101 kg]"}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q8h, drug form: inj [Greater Than or Equal To 101 kg]"}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q8h, drug form: inj, start: T+1;0600 [Greater Than or Equal To 101 kg]"}, {"type": "note", "data": "For low risk post operative patients only, on mechanical prophylaxis", "value": ""}, {"type": "order", "data": "ASA EC", "value": ""}, {"type": "sentence", "data": "162 mg, PO, q24h, drug form: tab-EC, start: T+1;1000"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH WITH CONTRAINDICATION TO ANTICOAGULANTS", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Mechanical prophylaxis contraindicated in:  - Peripheral vascular disease with absent pedal pulses  - Severe peripheral neuropathy  - Skin breakdown, ulcers, gangrene, cellulitis, or dermatitis  - Skin grafting within last 3 months  - Allergy to stocking or compression cuff materials  - Unable to size or apply properly due to deformity, recent surgery or trauma  - Acute stroke with immobility (unable to walk independently to the toilet) should not use graduated compression stockings or calf-length / below the knee Sequential Compression Devices. Thigh-length / full leg Sequential Compression Device should be utilized", "value": ""}, {"type": "order", "data": "Apply Below the Knee Graduated Compression Stocking", "value": ""}, {"type": "sentence", "data": "Apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Apply Full Leg Sequential Compression Devices", "value": ""}, {"type": "sentence", "data": "Apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Apply Below the Knee Sequential Compression Devices", "value": ""}, {"type": "sentence", "data": "Apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "No mechanical prophylaxis because of contraindication(s)"}]
